Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT06924359
Multimodal Ophthalmic Imaging and Plasma Biomarkers for the Early Detection of Alzheimer's Disease
Sponsor: Peking University First Hospital
View on ClinicalTrials.gov
Summary
With the accelerating global aging population, dementia has become a pressing worldwide issue. This project aims to identify specific plasma biomarkers and ocular indicators for the early detection of Alzheimer's disease (AD).
Key Details
Gender
All
Age Range
50 Years - Any
Study Type
OBSERVATIONAL
Enrollment
200
Start Date
2025-03-19
Completion Date
2027-08-31
Last Updated
2025-04-11
Healthy Volunteers
Not specified
Conditions
Interventions
DIAGNOSTIC_TEST
Multimodal Ophthalmic Imaging and plasma biomarker
Multimodal Ophthalmic Imaging and plasma biomarkers (Aβ42/40, p-tau181, p-tau217, NfL and GFAP）.
Locations (1)
Peking University First Hospital
Beijing, China